Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (111-120 of 858) with videos related to

Pageof 86
Sort By:
Journal of Thrombosis and Thrombolysis|March 25, 2005
Pathological changes in acute coronary syndromes: the role of statin therapy in the modulation of inflammation, endothelial function and coagulationKausik K Ray, Christopher P Cannon
Current Treatment Options in Cardiovascular Medicine|March 24, 2007
Lipid-independent pleiotropic effects of statins in the management of acute coronary syndromesKausik K Ray, Christopher P Cannon
Reviews in Cardiovascular Medicine|April 16, 2009
Cardiac resynchronization therapy. A perspective on PROSPECT and the continued search for predictors to CRT responseQuynh A Truong, Christopher P Cannon
The American Journal of Cardiology|October 3, 2008
Risk stratification and prognostic factors in the post-myocardial infarction patientChristopher P Cannon, Barry H Greenberg
Circulation|June 5, 2003
Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategyChristopher P Cannon, Alexander G G Turpie
Critical Pathways in Cardiology|March 11, 2010
The use and limitations of unfractionated heparinAmar Krishnaswamy, A Michael Lincoff, Christopher P Cannon
The New England Journal of Medicine|July 9, 2005
Intensive lipid lowering with atorvastatin in coronary diseaseChristopher P Cannon, Sabina A Murphy, Eugene Braunwald
Journal of the American College of Cardiology|March 27, 2010
High-density lipoprotein and coronary heart disease: current and future therapiesPradeep Natarajan, Kausik K Ray, Christopher P Cannon
Clinical Cardiology|June 24, 2005
Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trialJames L Januzzi, Jacqueline Buros, Christopher P Cannon, et al.
The American Journal of Cardiology|November 28, 2006
Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?Kausik K Ray, Christopher P Cannon, Peter Ganz
Pageof 86

Showing results (111-120 of 858) with videos related to

Sort By:
Pageof 86
Journal of Thrombosis and Thrombolysis|March 25, 2005
Pathological changes in acute coronary syndromes: the role of statin therapy in the modulation of inflammation, endothelial function and coagulationKausik K Ray, Christopher P Cannon
Current Treatment Options in Cardiovascular Medicine|March 24, 2007
Lipid-independent pleiotropic effects of statins in the management of acute coronary syndromesKausik K Ray, Christopher P Cannon
Reviews in Cardiovascular Medicine|April 16, 2009
Cardiac resynchronization therapy. A perspective on PROSPECT and the continued search for predictors to CRT responseQuynh A Truong, Christopher P Cannon
The American Journal of Cardiology|October 3, 2008
Risk stratification and prognostic factors in the post-myocardial infarction patientChristopher P Cannon, Barry H Greenberg
Circulation|June 5, 2003
Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategyChristopher P Cannon, Alexander G G Turpie
Critical Pathways in Cardiology|March 11, 2010
The use and limitations of unfractionated heparinAmar Krishnaswamy, A Michael Lincoff, Christopher P Cannon
The New England Journal of Medicine|July 9, 2005
Intensive lipid lowering with atorvastatin in coronary diseaseChristopher P Cannon, Sabina A Murphy, Eugene Braunwald
Journal of the American College of Cardiology|March 27, 2010
High-density lipoprotein and coronary heart disease: current and future therapiesPradeep Natarajan, Kausik K Ray, Christopher P Cannon
Clinical Cardiology|June 24, 2005
Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trialJames L Januzzi, Jacqueline Buros, Christopher P Cannon, et al.
The American Journal of Cardiology|November 28, 2006
Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?Kausik K Ray, Christopher P Cannon, Peter Ganz
Pageof 86